Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers.

Daraselia N, Wang Y, Budoff A, Lituev A, Potapova O, Vansant G, Monforte J, Mazo I, Ossovskaya VS.

Am J Cancer Res. 2012;2(1):93-103. Epub 2011 Nov 19.

2.

Loss of function genetic screens reveal MTGR1 as an intracellular repressor of beta1 integrin-dependent neurite outgrowth.

Ossovskaya VS, Dolganov G, Basbaum AI.

J Neurosci Methods. 2009 Mar 15;177(2):322-33. doi: 10.1016/j.jneumeth.2008.10.031. Epub 2008 Nov 6.

PMID:
19026687
3.

Protease-activated receptors: contribution to physiology and disease.

Ossovskaya VS, Bunnett NW.

Physiol Rev. 2004 Apr;84(2):579-621. Review.

4.

Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism.

de Garavilla L, Vergnolle N, Young SH, Ennes H, Steinhoff M, Ossovskaya VS, D'Andrea MR, Mayer EA, Wallace JL, Hollenberg MD, Andrade-Gordon P, Bunnett NW.

Br J Pharmacol. 2001 Aug;133(7):975-87.

5.

Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome.

Martens JW, Geller DH, Arlt W, Auchus RJ, Ossovskaya VS, Rodriguez H, Dunaif A, Miller WL.

J Clin Endocrinol Metab. 2000 Nov;85(11):4338-46.

PMID:
11095477
6.

The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.

Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM, Gudkov AV.

Nature. 1998 Jan 15;391(6664):295-8.

PMID:
9440695
7.

p53 modulation of anchorage independent growth and experimental metastasis.

Nikiforov MA, Hagen K, Ossovskaya VS, Connor TM, Lowe SW, Deichman GI, Gudkov AV.

Oncogene. 1996 Oct 17;13(8):1709-19.

PMID:
8895517
8.

Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.

Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, Kondratov R, Stark GR, Chumakov PM, Gudkov AV.

Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10309-14.

9.

Cell-specific effects of RAS oncogene and protein kinase C agonist TPA on P-glycoprotein function.

Stromskaya TP, Grigorian IA, Ossovskaya VS, Rybalkina EY, Chumakov PM, Kopnin BP.

FEBS Lett. 1995 Jul 17;368(2):373-6.

10.

Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.

Kopnin BP, Stromskaya TP, Kondratov RV, Ossovskaya VS, Pugacheva EN, Rybalkina EY, Khokhlova OA, Chumakov PM.

Oncol Res. 1995;7(6):299-306.

PMID:
8527864

Supplemental Content

Loading ...
Support Center